Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream
- 1 April 2002
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 46 (4) , 545-548
- https://doi.org/10.1067/mjd.2002.120444
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Squamous Cell Carcinoma Arising in Recurrent Respiratory Papillomatosis with Pulmonary Involvement: Emerging Common Pattern of Clinical Features and Human Papillomavirus Serotype AssociationLaboratory Investigation, 2000
- Imiquimod, a Topical Immune Response Modifier, Induces Migration of Langerhans Cells11The authors have declared a conflict of interest.Journal of Investigative Dermatology, 2000
- Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% creamJournal of the American Academy of Dermatology, 1999
- Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapyBritish Journal of Dermatology, 1999
- Imiquimod 5% cream (Aldara™)Expert Opinion on Investigational Drugs, 1998
- Prevalence of human papillomavirus types 16 and 18 in squamous‐cell carcinoma of the penis: A retrospective analysis of primary and metastatic lesions by differential polymerase chain reactionInternational Journal of Cancer, 1992
- Carcinoma in situ of penis Is distinction betweem erythroplasia of Queyrat and Bowen's disease relevant?Urology, 1990
- Soft-X-Ray Therapy in Bowen’s Disease and Erythroplasia of QueyratDermatology, 1985
- Human papillomavirus type‐16‐related DNA in genital Bowen's disease and in bowenoid papulosisInternational Journal of Cancer, 1983
- Treatment of erythroplasia of Queyrat with liquid nitrogen cryosurgeryBritish Journal of Dermatology, 1982